samedan logo
 
 
spacer
home > ebr
PUBLICATIONS

European BioPharmaceutical Review

 

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.

With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:

Advertising
Neil Clarke
Yvette Allen

Editorial
Danielle Levett

View the digital version of EBR

ebr
 
 
Featured in this issue
BioResearch and Innovation

Matthew Sleeman and Fabio Magrini at MedImmune review developments in using antibodies to treat autoimmune diseases and in other areas of unmet medical need, and hope that this will continue to stimulate research into the pathogenic mechanisms of autoimmunity.

BioDevelopment and Regulatory

Quality assurance should be integral to clinical development and trials to ensure the accuracy of test results. Martin Crockard at Randox describes different types of analyses and explains that the choice of scheme should be dependent on the size, duration and complexity of the trial.

  BioRegional

A new cGMP production centre is being built in Wallonia, allowing three companies who work in the field of regenerative medicines to come together to create one platform, where each will have their own production space and the support they need.

spacer
Edited by
Dr Helen Tayton-Martin,
Chief Operating Officer,
Adaptimmune Ltd
Published quarterly in
January, April,
July and October

 

 
Industry Events

C21 BioVentures

25-27 May 2010, California, US

C21 BioVentures™(C21) is the leading conference where early stage innovators, investors and pharma partners come together to do the deals that will make 2010 the year of global partnering. C21 features private company presentations, pre-scheduled face-to-face partnering meetings, expert panels, workshops and three days of networking opportunities at an intimate world-class resort and spa.
More info >>

 
News and Press Releases

Thermo Fisher Scientific ‘Plate of the Month’ Trial Lets Life Scientists Try the World’s Most Rigid High-Throughput PCR Plate

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will offer life scientists the opportunity to use Thermo Scientific ABgene Diamond Ultra PCR Plates on a trial basis as their 'Plate of the Month' for March 2010. This ultra-rigid 384-well PCR plate ensures reliable performance on medium- to high-throughput robotic handling systems for a smooth and efficient workflow.
More info >>

air transport logo

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement